1-109223996-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PM2PP2BP4
The NM_006513.4(SARS1):āc.155A>Gā(p.Asn52Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000397 in 1,613,464 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_006513.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SARS1 | NM_006513.4 | c.155A>G | p.Asn52Ser | missense_variant | 2/11 | ENST00000234677.7 | NP_006504.2 | |
SARS1 | NM_001330669.1 | c.155A>G | p.Asn52Ser | missense_variant | 2/12 | NP_001317598.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SARS1 | ENST00000234677.7 | c.155A>G | p.Asn52Ser | missense_variant | 2/11 | 1 | NM_006513.4 | ENSP00000234677.2 | ||
SARS1 | ENST00000369923.4 | c.155A>G | p.Asn52Ser | missense_variant | 2/12 | 5 | ENSP00000358939.4 | |||
SARS1 | ENST00000477544.5 | n.180A>G | non_coding_transcript_exon_variant | 2/5 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152140Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000278 AC: 7AN: 251462Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135906
GnomAD4 exome AF: 0.0000397 AC: 58AN: 1461324Hom.: 0 Cov.: 29 AF XY: 0.0000440 AC XY: 32AN XY: 727002
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152140Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74326
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 05, 2024 | The c.155A>G (p.N52S) alteration is located in exon 2 (coding exon 2) of the SARS gene. This alteration results from a A to G substitution at nucleotide position 155, causing the asparagine (N) at amino acid position 52 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at